DE69624116T2 - Verfahren zur behandlung von allergischem asthma - Google Patents

Verfahren zur behandlung von allergischem asthma

Info

Publication number
DE69624116T2
DE69624116T2 DE69624116T DE69624116T DE69624116T2 DE 69624116 T2 DE69624116 T2 DE 69624116T2 DE 69624116 T DE69624116 T DE 69624116T DE 69624116 T DE69624116 T DE 69624116T DE 69624116 T2 DE69624116 T2 DE 69624116T2
Authority
DE
Germany
Prior art keywords
allergic asthma
treating allergic
treating
asthma
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69624116T
Other languages
English (en)
Other versions
DE69624116D1 (de
DE69624116T3 (de
Inventor
B Fick
M Jardieu
B Schoenhoff
J Shire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24021032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69624116(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE69624116D1 publication Critical patent/DE69624116D1/de
Application granted granted Critical
Publication of DE69624116T2 publication Critical patent/DE69624116T2/de
Publication of DE69624116T3 publication Critical patent/DE69624116T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
DE69624116T 1995-07-27 1996-07-24 Verfahren zur behandlung von allergischem asthma Expired - Lifetime DE69624116T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50801495A 1995-07-27 1995-07-27
US508014 1995-07-27
PCT/US1996/012275 WO1997004807A1 (en) 1995-07-27 1996-07-24 Methods for treatment of allergic asthma

Publications (3)

Publication Number Publication Date
DE69624116D1 DE69624116D1 (de) 2002-11-07
DE69624116T2 true DE69624116T2 (de) 2003-06-18
DE69624116T3 DE69624116T3 (de) 2009-07-09

Family

ID=24021032

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69624116T Expired - Lifetime DE69624116T3 (de) 1995-07-27 1996-07-24 Verfahren zur behandlung von allergischem asthma

Country Status (16)

Country Link
EP (1) EP0841946B2 (de)
JP (1) JP4153560B2 (de)
CN (2) CN101172099B (de)
AR (1) AR003468A1 (de)
AT (1) ATE225185T1 (de)
AU (1) AU715338B2 (de)
CA (1) CA2226624C (de)
DE (1) DE69624116T3 (de)
DK (1) DK0841946T4 (de)
ES (1) ES2186796T5 (de)
IL (1) IL122733A (de)
MX (1) MX9800760A (de)
PT (1) PT841946E (de)
RU (1) RU2229288C2 (de)
WO (1) WO1997004807A1 (de)
ZA (2) ZA966075B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US6991790B1 (en) 1997-06-13 2006-01-31 Genentech, Inc. Antibody formulation
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
AU3065999A (en) * 1998-03-10 1999-09-27 Children's Hospital Of Philadelphia, The Compositions and methods for treatment of asthma
US6299875B1 (en) 1998-06-04 2001-10-09 Panacea Pharmaceuticals, Llc Methods to block IGE binding to cell surface receptors of mast cells
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
CA2423227C (en) * 2000-10-12 2011-11-29 Genentech, Inc. Reduced-viscosity concentrated protein formulations
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
EP1558646A2 (de) 2002-11-08 2005-08-03 Ablynx N.V. Antikörper aus camelidae gegen interferon-gamma und ihre verwendungen
CA2505326A1 (en) 2002-11-08 2004-05-21 Ablynx N.V. Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
DE202006020194U1 (de) * 2006-03-01 2007-12-06 Bioceuticals Arzneimittel Ag G-CSF-Flüssigformulierung
WO2008092993A1 (en) * 2007-01-29 2008-08-07 Valtion Teknillinen Tutkimuskeskus Method for producing novel ige based reagents
AR065368A1 (es) 2007-02-15 2009-06-03 Astrazeneca Ab Anticuerpos para moleculas de ige
EP2052736A1 (de) * 2007-10-26 2009-04-29 Nycomed Danmark ApS Parathyroidhormon-Formulierungen und ihre Verwendungen
WO2009082648A1 (en) * 2007-12-21 2009-07-02 Inspiration Biopharmaceuticals, Inc. Stabilized factor ix formulations containing trehalose
EP2234600B1 (de) * 2007-12-21 2014-08-20 F. Hoffmann-La Roche AG Antikörper-formulierung
CA2738243C (en) * 2008-10-29 2020-09-29 Wyeth Llc Formulations of single domain antigen binding molecules
CN105646643A (zh) 2008-10-29 2016-06-08 阿布林克斯公司 单域抗原结合性分子的纯化方法
MX337432B (es) 2009-12-15 2016-03-04 Ascendis Pharma As Composicion de la hormona del crecimiento seca enlazada transitoriamente a un portador del polimero.
CN102533704A (zh) * 2010-12-30 2012-07-04 上海雅心生物技术有限公司 即配即用型的胰蛋白酶制剂
EP2691112B1 (de) * 2011-03-31 2018-05-23 Merck Sharp & Dohme Corp. Stabile formulierungen aus antikörpern gegen den menschlichen pd (programmed death)-1-rezeptor und behandlungen damit
SG11201401360XA (en) * 2011-10-25 2014-05-29 Onclave Therapeutics Ltd Antibody formulations and methods
JP6549104B2 (ja) 2013-09-27 2019-07-24 ハンミ ファーマシューティカル カンパニー リミテッド 持続型ヒト成長ホルモン製剤
CN104707146B (zh) * 2013-12-16 2019-04-16 浙江海正药业股份有限公司 一种含有阿达木单抗的药物组合物
GB201610198D0 (en) 2016-06-10 2016-07-27 Ucb Biopharma Sprl Anti-ige antibodies
BR112019022873A8 (pt) 2017-05-02 2023-04-11 Merck Sharp & Dohme Formulação, e, vaso ou dispositivo de injeção.
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
WO2019019998A1 (zh) * 2017-07-25 2019-01-31 江苏恒瑞医药股份有限公司 一种il-15蛋白复合物药物组合物及其用途
CN110732023B (zh) * 2018-07-18 2023-06-16 江苏恒瑞医药股份有限公司 一种her2抗体药物组合物及其用途
IL299747A (en) 2020-07-10 2023-03-01 Shanghai Jemincare Pharmaceutical Co Ltd Transgenic antibody against IGE and its application
WO2024017241A1 (en) * 2022-07-18 2024-01-25 Suzhou Transcenta Therapeutics Co., Ltd. Stable pharmaceutical formulation comprising anti-gremlin1 antibody

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
AU616916B2 (en) * 1987-11-20 1991-11-14 Kissei Pharmaceutical Co. Ltd. 4h-quinolizin-4-one compounds exhibiting therapeutic activities
EP0407392B2 (de) * 1987-12-31 1998-10-28 Tanox Biosystems, Inc. Antigene epitope, die sich ausschliesslich auf ige-tragenden b-lymphocyten befinden
JPH07507923A (ja) * 1992-03-20 1995-09-07 イムネット ヒトモノクローナル抗体およびヒトモノクローナル抗体製造法
JPH07118168A (ja) * 1993-10-19 1995-05-09 Tomoyasu Ra ＩｇＥ産生抑制剤
PT589840E (pt) * 1992-09-24 2004-08-31 Tanox Biosystems Inc Anticorpos monoclonais reformulados contra um isotipo de imunoglobulina
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
EP0841946B2 (de) 2008-10-15
PT841946E (pt) 2003-02-28
IL122733A0 (en) 1998-08-16
CN101172100A (zh) 2008-05-07
CA2226624C (en) 2013-07-16
IL122733A (en) 2001-09-13
CN101172099B (zh) 2012-02-15
RU2229288C2 (ru) 2004-05-27
MX9800760A (es) 1998-04-30
DE69624116D1 (de) 2002-11-07
ZA966240B (en) 1998-01-23
JPH11510172A (ja) 1999-09-07
CN101172099A (zh) 2008-05-07
JP4153560B2 (ja) 2008-09-24
DE69624116T3 (de) 2009-07-09
WO1997004807A1 (en) 1997-02-13
DK0841946T3 (da) 2003-02-10
ZA966075B (en) 1998-01-19
CA2226624A1 (en) 1997-02-13
DK0841946T4 (da) 2009-02-16
AR003468A1 (es) 1998-08-05
ES2186796T5 (es) 2009-04-01
AU715338B2 (en) 2000-01-20
ATE225185T1 (de) 2002-10-15
AU6638196A (en) 1997-02-26
EP0841946B1 (de) 2002-10-02
ES2186796T3 (es) 2003-05-16
EP0841946A1 (de) 1998-05-20

Similar Documents

Publication Publication Date Title
ATE225185T1 (de) Verfahren zur behandlung von allergischem asthma
DE69603838D1 (de) Verfahren zur behandlung von gasen
DE696923T1 (de) Verfahren zur behandlung endo-ostealer materialen
ATE230606T1 (de) Verfahren zur vorbeugung und behandlung von allergien
DE69701714T2 (de) Verfahren zur behandlung von glassubstraten
DE69331469T2 (de) Verfahren zur behandlung von abfällen
DE69726289D1 (de) Verfahren und zusammensetzung zur behandlung von substraten bezüglich benetzbarkeit
DE69417018D1 (de) Verfahren zur behandlung von teilchenmaterial
DE69613446T2 (de) Verfahren zur Behandlung von wässerigem Strom
DE69526796D1 (de) Verfahren zur inhibierung von pflanzenkrankheiten
DE69624625D1 (de) Verfahren und Vorrichtung zur Behandlung von Organohalogenkomponenten
DE69518824T2 (de) Verfahren zur behandlung von bremsscheiben
ATE232919T1 (de) Zusammensetzung zur behandlung von wäsche sowie verfahren hierfür
ATE371453T1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69609082D1 (de) Verfahren zur behandlung von abfällen
DE69802904T2 (de) Verbessertes verfahren zur behandlung von aluminiummonohydratreichen bauxiten
DE69905263T2 (de) Verfahren zur dekorativen behandlung von oberflächen
DE69429341D1 (de) Verfahren zur behandlung von flüssigkeiten
DE69301029D1 (de) Verfahren zur behandlung und leimung von papiersubstraten
DE69533397D1 (de) Verfahren zur behandlung von hypertonie
DE69634207D1 (de) Verfahren zur behandlung von böden und/oder schüttgütern
DE69507537T2 (de) Verfahren zur Behandlung von Strukturen mit Silikonzusammensetzungen
ATA82393A (de) Verfahren zur behandlung von gasen
DE69504147D1 (de) Verfahren und Vorrichtung zur Behandlung von Aerosolen
ATA183195A (de) Verfahren zur behandlung von organen und vorrichtung hierfür

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings